Abeona Therapeutics ABEO
NASDAQ ABEO
$2.60 +0.18 (+7.44%)
At close: Nov 16, 2026 · 4:00 PM EST

Abeona Therapeutics (ABEO) Cash & Equivalents (2009 - 2026)

Updated

Abeona Therapeutics (ABEO) posted Cash & Equivalents of $66.28 million for Q3 2026, down 20.0% from $82.88 million a year earlier but up 17.9% from the prior quarter.

Analysis

Abeona Therapeutics (ABEO) Cash & Equivalents (2009 - 2026) Analysis & Trends

At the end of FY2025, Abeona Therapeutics' Cash & Equivalents came in at $78.44 million, up 231.0% from FY2024.

  • Annual Cash & Equivalents has increased for three consecutive years, with a five-year compound annual growth rate of 42.0% (FY2020 to FY2025).
  • In prior years, Abeona Therapeutics' Cash & Equivalents was $23.7 million in FY2024 (+60.0%), $14.81 million in FY2023 (+1.8%), $14.56 million in FY2022 (-62.5%) and $38.83 million in FY2021 (+186.1%).
  • Quarterly Cash & Equivalents has run from a low of $5.02 million in Q1 2023 to a high of $163.54 million in Q2 2025 over five years.
  • On a year-over-year basis, Cash & Equivalents increased in five of the last eight quarters, with growth averaging 158.2%.
  • The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q2 2024, with growth of 429.7%; the weakest was Q1 2023, with a decline of 80.9%.
  • According to Business Quant data, Cash & Equivalents for the three prior quarters was $56.23 million (Q2 2026), $61.37 million (Q1 2026) and $78.44 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 16.91 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 10.77 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 9.55 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - 400.00 Mn
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 7.94 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 6.44 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 1.82 Bn
10 Abeona Therapeutics 149.28 Mn -492.16 Mn 7.78 Mn 66.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 66.28 Mn
Jun 30, 2026 56.23 Mn
Mar 31, 2026 61.37 Mn
Dec 31, 2025 78.44 Mn
Sep 30, 2025 82.88 Mn
Jun 30, 2025 163.54 Mn
Mar 31, 2025 15.94 Mn
Dec 31, 2024 23.70 Mn
Sep 30, 2024 16.06 Mn
Jun 30, 2024 34.76 Mn
Mar 31, 2024 17.90 Mn
Dec 31, 2023 14.81 Mn
Sep 30, 2023 5.05 Mn
Jun 30, 2023 6.56 Mn
Mar 31, 2023 5.02 Mn
Dec 31, 2022 14.56 Mn
Sep 30, 2022 11.07 Mn
Jun 30, 2022 12.02 Mn
Mar 31, 2022 26.22 Mn
Dec 31, 2021 38.83 Mn
API Access

Abeona Therapeutics Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ABEO&period=max&api_key=YOUR_API_KEY